Mieloma m?ltiple - Gu?a para el paciente
IMF DNA BANK IDENTIFIES GENETIC VARIATIONS RELATED TO PREDISPOSITION TO MM AND RESPONSE TO TX
LIGHTS, CAMERA, CURE! The IMF's 15th Anniversary Gala a Winner!
1070
Blood Drive dedicated to IMFer Michael Tuohy
The Role Of The Ras Oncogene In Multiple Myeloma Spread
Autologous Bone Marrow And Stem Cell Transplantation For Multiple Myeloma, part 1
Myeloma Minute - January 18, 2006
Autologous Bone Marrow and Stem Cell Transplantation For Multiple Myeloma, part 2
SZPICZAK MNOGI PORADNIK DLA PACJENT?W
Myeloma Minute - October 25, 2007
Guida Per Il Paziente
Introduction to Proteasome Inhibition
THE INTERNATIONAL MYELOMA FOUNDATION CONGRATULATES FRIEND AND COLLABORATOR DR. LUC MONTAGNIER FOR BEING AWARDED THE NOBEL PRIZE
IMF Multiple Myeloma Patient Handbook 2008/2009

VELCADE® (Bortezomib) verstehen
Conociendo VELCADE® (bortezomib) para inyección
IMF Sponsors Symposium Preceding 46th Annual ASH Meeting
Hastalara y?nelik ek kitabı
BANK ON A CURE® "GENE BANK" RESEARCHERS IDENTIFY PATHWAYS THAT MEDIATE SIDE EFFECTS FROM WIDELY-USED MYELOMA TREATMENT
INTERNATIONAL MYELOMA FOUNDATION (IMF): STUDI MULTIPLI PRESENTATI IN OCCASIONE DELLA CONFERENZA MONDIALE SUL CANCRO INDICANO NUOVE TERAPIE CHE CAMBIANO LA PROSPETTIVA PER I PAZIENTI AFFETTI DA NEOPLASIE EMATOLOGICHE
INTERNATIONALE MYELOMSTIFTUNG: MEHRERE STUDIEN AUF GLOBALER KREBSKONFERENZ ZEIGEN DIE VERBESSERUNG DER AUSSICHTEN FÜR BLUTKREBSPATIENTEN DURCH NEUE THERAPIEN
ASH 2005 G?ncel ?zet
THE INTERNATIONAL MYELOMA FOUNDATION: MULTIPLE STUDIES AT GLOBAL CANCER CONFERENCE SHOW NEW THERAPIES CHANGING THE OUTLOOK FOR PATIENTS WITH BLOOD CANCERS

LA FONDATION INTERNATIONALE DU MYÉLOME: DES ÉTUDES MULTIPLES PRÉSENTÉES À LA CONFÉRENCE MONDIALE DE CANCÉROLOGIE INDIQUENT QUE LES NOUVELLES THÉRAPIES CHANGENT LE PRONOSTIC DES PATIENTS ATTEINTS DE CANCER DU SANG


LA FUNDACIÓN INTERNACIONAL DEL MIELOMA: MÚLTIPLES ESTUDIOS EN LA CONFERENCIA MUNDIAL DEL CÁNCER DEMUESTRAN QUE LAS NUEVAS TERAPIAS ESTÁN CAMBIANDO EL PRONÓSTICO DE PACIENTES CON CÁNCER DE SANGRE


February 13, 2004 Myeloma Minute
Excerpts from Acceptance Speeches at Cirque de la Vie
What's New In Research - February 12, 2004
Applying For An International Myeloma Foundation Research Grant
EMEA Marketing Approval of REVLIMID® is Important Advance for Patients in Europe
14th Anniversary Ribbon of Hope Gala Honorees:
QUALITY OF LIFE AWARD
IMF 2001 Research Grant Awards
IMF 2000 Research Grant Awards
The Role Of Osteoclast Differentiation Factor TRANCE in Myeloma-Associated Bone Destruction
IMF 1999 Research Grant Awards
Immune-Mediated Clearance Of AL-Amyloid
Dendiric Cell-Based Vaccination With Idiotype For Amyloidosis And Post-Transplant Myeloma
Isolation Of Myeloma-Cytotoxic T Lymphocytes - Identification of Myeloma Tumor Antigents
Targeted Radioimmunotherapy For The Treatment Of Myeloma: A Preliminary Pharmacodynamic Study
1998 IMF Research Grant Awards
Kaposi's Sarcoma-Associated Herpesvirus Cytokines in the Oncogenesis of Multiple Myeloma
Characterization of 14q32 Translocations In Multiple Myeloma
Moncolonal Antibody Directed Immunotherapy For The Treatment Of Multiple Myeloma
Molecular Mechanisms Of Myeloma Cell Resistance To Apoptosis
1997 IMF Research Grant Awards
IMF 1996 Research Grant Award
IMF 1995 Research Grant Award
IMF to Establish European Base of Operations in Germany
Myeloma Minute - December 7, 2005
FDA Approves Aredia For The Treatment Of Myeloma Bone Disease
Important New Blood Cancer Initiative Announced on Capital Hill
What's New In Research - May 23, 2003
The Unknown Patient Reports from the IXth International Myeloma Workshop
IXth International Myeloma Workshop - Thursday, May 22nd, 2003
Complementary and Alternative Medicine
Richie Test
Barisa's Test
The Page You Requested Is Not Available
多発性骨髄腫
患者の手引き
СПРАВОЧНИК ПАЦИЕНТА
Множественная Миелома
Рак Костного Мозга
2007

Patientenhandbuch
Robert A. Kyle, MD
Forming A Myeloma Support Group
June Brazil in Memoriam
Upcoming Professional Meetings
Forming A Support Group - Sample Flyer
Sample Support Group Newsletter
June, 2001 Senate Hearing on Blood Cancer Research: A personal photo journal
Senate hearing on Blood Cancer Research
LE MY?LOME MULTIPLE - GUIDE DU PATIENT

Hand Printed Christmas Cards
Myeloma Minute - November 13, 2007
The new site
The use of VELCADE® in a frontline setting.
Introduction
Oncogenic Events
The Malignant Clone In Myeloma
Innovative Technologies
Signaling and Microenvironment
Angiogenesis In Multiple Myeloma
Treatment Modalities and Symptom Management
Bone Metabolism, Bone Disease, and the Bisphosphonates
Allogeneic and Autologous Transplantation
Thalidomide: Clinical Outcomes
Vaccine Strategies in Multiple Myeloma
Immunotherapies and Control Of Residual Disease
New Therapies
Helen Bos
A Brief History of the IMF
Comprensione Revlimid®
Multiples Myelom Handbuch Zur Erkrankung Und Behandlung
January 3, 2002: IMF Myeloma Minute
Meet The Staff
Senators Urge Medicare to Cover PET Scans for Myeloma Patients
Edmundo Gorga
Bart Barlogie, M.D., Ph.D.
Raymond Alexanian, M.D.
Alan Solomon, MD
Kenneth C. Anderson, M.D.
Myeloma Minute - October 4, 2005
Giuseppe Avvisati, MD
Jean-Luc Harousseau
Regis Battaile, MD
Daniel R. Bergsagel, MD
Joan Blad?, M.D
Mario Boccadoro, MD
Y.C. Chen, MD
J. Anthony Child, MD
Meletios-Athanassios Dimopoulos, MD
Brian G.M. Durie, MD
G?sta Gahrton, MD
Dr. Vania Hungria
Douglas Edward Joshua, MD
Tadamitsu Kishimoto, MD, Ph.D.
Heinz Ludwig, MD
James S. Malpas, MD
H?ken Mellstedt, M.D., Ph.D.
Angelina Rodriguez Morales, MD
Dorotea Fantl, MD
Ian Franklin, MD
Gregory R. Mundy, MD
Martin Oken, MD
Linda Pilarski, MD
Ray Powles, MD
Pieter Sonneveld, MD
Benjamin Van Camp, MD Ph.D.
LLM ACT: Leukemia, Lymphoma and Myeloma: Action, Communication, Teamwork
National Cancer Institute Leukemia, Lymphoma And Myeloma Progress Review Group (PRG)
Access to Cancer Therapies Act, H.R. 1624 / S. 913, Medicare Coverage of Anti-Cancer Therapies
Access to Cancer Clinical Trials Act H.R. 967
Department of Defense Research Program Success of Cancer Research Initiatives at DoD
IMF 11th Anniversary Gala
Thank You to the Sponsors of the IMF Website!
Anonymous #1
Bill Bauknecht
Nancy Bengston
Submit a Myeloma Survivor Story
Don Biddison
What is an autologous stem cell transplant and am I a candidate for one?
What is an M spike and is it different from the M Protein?
What is nonsecretory myeloma?
Myeloma Minute
耐心的手册
A Guide to Creative Giving
Peter Coulthurst
What's New in Research - October 8, 2002
Learn Why the IMF is Supporting OVAC Advocacy Days
Report from One Voice Against Cancer Advocacy Day - June 3-4, 2002
Privacy Policy
April 9, 2002: IMF Myeloma Minute
March 14, 2002: IMF Myeloma Minute Special Report
March 19, 2002: IMF Myeloma Minute
Caregiver Manual - Chapter One
Caregiver Manual - Chapter Two
Chapter Three: Symptom Management at Home
Chapter Four: Goals of Care in Progressive Illness
Chapter Five: You Have Needs, Too
Chapter Six: Specific Illnesses - Cancer
Chapter Seven: Where to Find Help
Chapter One: Workbook Forms
Chapter Two: Workbook Forms
Chapter Three: Workbook Forms
Barbara Shultz
Michael Smith
March 25, 2002: IMF Myeloma Minute Special Report - Online Chat
March 26, 2002: IMF Myeloma Minute
Arnold Gassan
Jean Greening
Barb H.
Mike Hamilton
Warren Harre
Joel Harris
Edyth Henderson
Chantal Heon
Lem Hill
Roz Jarrett
Pat Jent
Rosanne Kalick
Catherine Kerr
April 2, 2002: IMF Myeloma Minute
Mindy Lernihan
B?rje Kyrklund
Charlotte Longo
Gayle MacNichol
Cheryl Suzanne Spiese
Ronnie MacIntyre
Gene McLaughlin
Melvyn
Bill Miller
John Nesci
Pat Parsons
Kathy Pedersen
Jerry Petet
Bernard Pilcher
Patricia Meyer
Joanie Pinson
Peter Randlov
12/13/01 IMF Myeloma Minute
Jane Simpson
Sandra Smith
Howard Stock
Bob Rinker
Dorothy Russell
John Peter Thompson
Peter Tischler
Audrey Thornton
G.S. Viswanathan
Roberta Winter
Lori Watson
June Brazil
George Burroughs
Anonymous #2
Collette Barkley
Theresa Cornelis
Val Cousins
Robert Divola
Bob Eilers
Don Friedel
Allen Gifford
Larry Owens
Jim Gambrill
Rob Hain
David Hanson
Harold Hayden
Carl Jenkins
Ray Jones
Alf Lied
Denver Wayne Little
Joe Luby
Information in German About Multiple Myeloma
Frank Meyers
Thomas Bland
Ronald Niedrauer
Maggie O'Hara
Terry O'Neill
Bill Otterson
Ellen Palmer
June Pruitt
Mario Ranelli
Philip Scheble
Glenn Schroer
Mike Wolak
Calling All Kids: Youth Artists Wanted!
Help Design the IMF's Holiday Greeting Cards
Myeloma Minute
Report on the VII International Workshop on Multiple Myeloma, Stockholm, Sweden, Sept. 1-5, 1999
Sept. 1, 1999 -- VII International Workshop, Stockholm Sweden
Sept. 2, 1999 -- VII International Workshop on Multiple Myeloma, Stockholm, Sweden
Sept. 3, 1999 -- VIIth International Myeloma Workshop, Stockholm Sweden
Sept. 4, 1999 -- VIIth International Workshop On Multiple Myeloma, Stockholm, Sweden
Sept. 5, 1999 -- VIIth International Workshop On Multiple Myeloma, Stockholm, Sweden
September 10,2001 Myeloma Minute
June 13, 2002: IMF Myeloma Minute
Help Support the Creation of a Multiple Myeloma Awareness Stamp
Postage Stamp Letter Writing Campaign
Leonard Zakim
What's New In Research - March 6, 2003
Thalidomide Editorial
Roger Neilson Editorial
Environment Editorial
Letters to the Editor
Myeloma Minute
Reed Gaulding
DANIEL EGIL BERGSAGEL, CM, MD, D.Phil
April 25, 1925 ? October 20, 2007
Myeloma Today Fall 2007 in PDF
THE INTERNATIONAL MYELOMA FOUNDATION SAYS NEW THALIDOMIDE DATA CONFIRMS SURVIVAL BENEFITS FOR OLDER PATIENTS
Myeloma Minute
Past Professional Meetings
October 16, 2001 Myeloma Minute
OMNI Network
11/5/01 Myeloma Minute
Past Professional Meetings
Past Meetings
Programs & Meetings
October 26, 2001 Myeloma Minute
What is a mini-allo transplant?
11/9/01 Myeloma Minute
IMF Myeloma Minute
May 30, 2002: IMF Myeloma Minute
May 28, 2002: IMF Myeloma Minute
Clinical Trials Listing from Acurian
Multiple Myeloma: New Insights and Therapeutic Approaches
IMF Launches Innovative New Program for Support Groups
Myeloma Expert Dr. Phil Greipp to Run in Olympic Torch Relay
IMF Myeloma Minute
IMF Reports from 43rd ASH Annual Meeting
IMF Reports on ASH Annual Meeting - Abstract #1822
Myeloma Minute Special ASH Update #1
IMF ASH Update #2
IMF Announces 2002 Research Grant Recipients
ASH Update #3
ASH 2001 Coporate Friday: Advances In Multiple Myeloma Pathogenesis And Treatment
January 10, 2002: IMF Myeloma Minute
January 17, 2002: IMF Myeloma Minute
IMF Myeloma Minute
An IMF Myeloma Minute Special Report
An IMF Myeloma Minute Special Report Regarding Zometa
January 31, 2002: IMF Myeloma Minute
February 7, 2002: IMF Myeloma Minute
February 14, 2002: IMF Myeloma Minute
Fashions-4-A-Cure Donation Form
Facts About Zometa
February 26, 2002: IMF Myeloma Minute
Coming Soon: IMF Myeloma Manager Patient Flow Sheet
National Cancer Institute Clinical Trials Educational Materials
IMF Myeloma Minute: March 12, 2002
What You Need to Know About Advocacy Day
Sign Up For The Myeloma Minute
Myeloma Minute - November 28, 2004
Mod 2 test
Module 1: Screening, Diagnosis, and Staging of Multiple Myeloma
Recent Newspaper Article Highlights the Importance of OVAC Advocacy Day
April 16, 2002 IMF Myeloma Minute
April 16, 2002: IMF Myeloma Minute
Multiple Myeloma Awareness Week 2002!
International Myeloma Foundation Patient Handbook-- Korean Language Edition
April 23, 2002: IMF Myeloma Minute
April 30, 2002: IMF Myeloma Minute
May 7, 2002: IMF Myeloma Minute
May 14, 2002: IMF Myeloma Minute
Expert Opinions On Multiple Myeloma
May 21, 2002: IMF Myeloma Minute
IMF's Multiple Myeloma Quilt of Courage 1
IMF's Susie Novis featured in LA Time Article
June 25, 2002: IMF Myeloma Minute
WHAT IS MULTIPLE MYELOMA?
Myeloma Manager™ Webinar Replay
ASCO 2008 Highlights for Physicians
The IMF Welcomes Our International Partners
OVAC 2002: IMF Participates In One Voice Against Cancer Advocacy Day
OVAC 2002 Advocacy Day Senate Hearing: Written Testimony of Susie Novis
OVAC 2002 Advocacy Day Senate Hearing: Oral Testimony of Susie Novis
July 16, 2002 IMF Myeloma Minute
June 6, 2002: IMF Myeloma Minute
June 18, 2002: IMF Myeloma Minute
GLOSSARY OF TERMS & DEFINITIONS
WHAT IS THE TREATMENT FOR MYELOMA?
IMF Myeloma Minute: July 2, 2002
July 9, 2002: IMF Myeloma Minute
What's New In Research - December 19, 2002
Hartmut Goldschmidt, MD
December 3, 2002 Myeloma Minute
FAQ about Skeletal Targeted Radiotherapy (STR)
Expert Opinions On Multiple Myeloma
July 23, 2002 IMF Myeloma Minute
RESEARCH UPDATE: Elliot Epner, MD, PhD
UPDATE - Developing the Second Generation Myeloma Chip: Jaime O. Claudio, Ph.D
IMF 2002 Research Grant Awards
UPDATE - Role of Novel Signaling Routes and c-Kit in MM Proliferation: A. Pandiella, MD, PhD
UPDATE - Use of Ras Signaling Inhibitors to Combat Myeloma - Michael A. Morgan
UPDATE - Pathophysiological Relevance of VEGF in Multiple Myeloma - Klaus Podar
The IMF Goes to Washington in the Special Edition of Myeloma Today
July 30, 2002 IMF Myeloma Minute
Defining the Disease
Initial Detection and Diagnosis
Expert Opinions on Multiple Myeloma
Note: This program is in the process of revision.
Full Text of Greg Brozeit's Cancer Landscape presentation at the June 2002 OVAC Advocacy Day.
NCI Director Andrew von Eschenbach's Speech Highlights Patient-Family Seminar
Bibliography for Module 1
ASCO 2008 Highlights for Patients
WALL OF MIRACLES PRESIDENT'S CIRCLE
WALL OF MIRACLES BENEFACTORS CIRCLE
WALL OF MIRACLES FOUNDERS CIRCLE
WALL OF MIRACLES PARTNERS CIRCLE
Monoclonal Gammopathy of Undetermined Significance: Robert A. Kyle, MD
Defining the Disease
testing create
Significance of Chromosome 13 Deletions in Multiple Myeloma: Seema Singhal, MD
Initial Detection and Diagnosis
Module 1 Bibliography
Prognosis and Staging
Planning Treatment
Monitoring Patients
Complications Associated With This Disease
Module 2: First-Line Treament of Multiple Myeloma
References for Module 2
Overview of Treatment Options
testing
Transplants
Radiotherapy, Bisphosphonates, and Other Supportive Therapies for Multiple Myeloma
Thalidomide
August 6, 2002 IMF Myeloma Minute
Maintenance Therapy
What's New in Research - August 27, 2002
Relapse
Therapies for Relapsed or Refractory Disease
Complications of Treatment for Disease
Diseases Related to Multiple Myeloma
Module 3: Post-Treatment Maintenance, Relapsed or Refractory Disease, and Other Issues
Screening, Diagnosis, and Staging of Multiple Myeloma
Ongoing Phase II Study of 166Ho-DOTMP in Patients with Multiple Myeloma
Inspired Venture Program in Multiple Myeloma
August 13, 2002 IMF Myeloma Minute
What's New in Research - August 20, 2002
Myeloma at the Movies!
August 20, 2002 IMF Myeloma Minute
August 27, 2002 IMF Myeloma Minute
BANK ON A CURE?
The Myeloma Forum
Best of ASH
Myeloma Minute - September 13, 2006
June Brazil Helping Hand Award
The Founding of the IMF
Back by Popular Demand! The Myeloma Quilt of Courage!
Dear Reader
Ribbon of Hope ? Making a World of Difference
Capire La Terapia con Bifosfonati
New! MM Interactive
What's New in Research - September 4, 2002
September 4, 2002 IMF Myeloma Minute
Myeloma Minute Subscription Issues
What's New in Research - September 11, 2002
HOPELINK?An open, searchable database of clinical trials, customized for the IMF.
What's New in Research - September 17, 2002
September 17, 2002 IMF Myeloma Minute
FDG PET Reassures and Reveals High Risk Multiple Myeloma
September 11, 2002 IMF Myeloma Minute
What's New in Research - September 24, 2002
Elections, Lame Ducks, and Unfinished Business
September 24, 2002 IMF Myeloma Minute
Dear Reader
The IMF Goes to Washington
What Is the Bypass Budget?
Next Steps
Washington Comments
What's New in Research - October 1, 2002
October 2, 2002 IMF Myeloma Minute
The Text of Susie Novis' Acceptance Speech After Receiving the Joseph Michaeli Award
OVAC Grassroots Training
QUESTIONS TO ASK YOUR DOCTOR
IF FRONTLINE THERAPY IS NOT WORKING
WHAT CAUSES MYELOMA?
October 8, 2002 IMF Myeloma Minute
What's New in Research - October 15, 2002
Oral Drug Bill Update
October 15, 2002 IMF Myeloma Minute
What's New in Research - October 22, 2002
One Voice Against Cancer Grassroots Training
October 22, 2002 IMF Myeloma Minute
Martin Boling
Daniel Stephenson
C. Sagnard
David Emerson
Barbara Jewell
Marla Barnett
UPDATE - Study of Homing Mechanisms Involved in the Biology of MM: Ivan Van Riet, Ph.D
October 29, 2002 IMF Myeloma Minute
November 5, 2002 IMF Myeloma Minute
What's New in Research - November 12, 2002
May 2, 2003 Myeloma Minute
IMF Holds First MM Interactive Patient/Family Seminar In Seattle
One Voice Against Cancer Coalition Discusses Impact of Election
Jesus Fernando San Miguel
Education, Advocacy, and Awareness:
Chicago IMF Patient & Family Seminar
Education, Advocacy, and Awareness:
Cancer, Civil Rights, and Political Placebos
Meet the IMF: Allan Weinstein Joins the IMF Board of Directors
November 13, 2002 IMF Myeloma Minute
What's New in Research - November 19, 2002
November 19, 2002 IMF Myeloma Minute
Myeloma Minute - September 21, 2005
The IMF Welcomes David Siegel, MD, PhD
IMF Hotline Coordinators Answer Your Questions
The International Myeloma Foundation?s CDC Initiative
Revlimid? (Lenalinomide): Where Do We Stand?
IMF Honors Kenneth C. Anderson, MD with 2005 Robert A. Kyle Lifetime Achievement Award
IMF Around the Globe
Myeloma stem Cells: Attacking the Disease at its Source
Dear Reader
The Myeloma Matrix Part I (Phase II -> FDA Approved)
Myeloma Minute - August 9, 2005
STAGING & PROGNOSTIC CLASSIFICATION
BASIC FACTS ABOUT MYELOMA
Myeloma Quilt of Courage #4 - Rolf H. Meier
Myeloma Quilt of Courage #4 - To My Dad
Myeloma Quilt of Courage #4 - In Loving Memory
Myeloma Quilt of Courage #4 - Gale
Myeloma Quilt of Courage #4 - George Plesha
Myeloma Quilt of Courage #4 - Robert Warren Evans
Myeloma Quilt of Courage #4 - Sandy
Myeloma Quilt of Courage #4 - Frankie Salgado
Myeloma Quilt of Courage #4 - Frankie Salgado
Myeloma Quilt of Courage #4 - Irene Anderson
NCI's Strategic Plans for Addressing Recommendations of the LLM Progress Review Group
What's New In Research - December 3, 2002
Myeloma Quilt of Courage #4 - Butterfly
IMF World Events
Dear Reader
Neuropathy and Monoclonal Gammopathy
If You Have Cancer: What You Should Know About Clinical Trials
Si Tiene Cancer: lo que deber?a saber sobre estudios cl?nicos
Facing Forward: Life After Cancer
Siga Adelante: la vida despu?s del tratamiento del c?ncer
Das Revlimid® Handbuch „Revlimid® verstehen"
Understanding Balloon Kyphoplasty and Myeloma-Induced Vertebral Compression Fractures
Immunomedics Reports on New Humanized Antibody Therapeutics at American Society of Hematology Mtg
New Data From Velcade(TM) For Injection Crest Study Indicate Responses In Patients With MM
Early Clinical Results Suggest Genasense(TM) May Be Useful for Patients With Highly Resistant MM
Complete Response Rate and Patient Survival Data for STR Presented at ASH
EntreMed Thalidomide Analog Demonstrates Further Progress
Data on THALOMID? in Numerous Hematological Malignancies Presented At Annual Meeting of ASH
Millennium Pharma -2: Drug Study Shows 35% Response Rate
Final Phase II Data Presented from VELCADE(TM) for Injection Summit Trial
Geron Corporation Reports Progress in Multiple Telomerase-Based Cancer Therapies
December 11, 2002 Myeloma Minute
Developing the Second Generation Myeloma Chip
PS-341: The Patient Experience
Multiple Musicians Against Multiple Myeloma
What A Difference A Year Makes
Advocacy Update: Connecting the Dots
Multiple Myeloma Group In France
Myeloma Quilt of Courage #1 - Claire Landers
Myeloma Quilt of Courage #1 - Sandra Curtis
Myeloma Quilt of Courage #1 - Kathy Backus
Myeloma Quilt of Courage #1 - Trudy Fobbs
Myeloma Quilt of Courage #1 - Frances Lopes
Myeloma Quilt of Courage #1 - Mary Watson
Myeloma Quilt of Courage #1 - Liz Holz, Barbara Sullivan, Ann Hilario, Carolyn Baker
Myeloma Quilt of Courage #1 - Justine Springberg
Myeloma Quilt of Courage #1 - Amy Brown
Myeloma Quilt of Courage #1 - Susan Buzzell
Myeloma Quilt of Courage #1 - Marcia Sawyer
Myeloma Quilt of Courage #1 - Judith Copple
Myeloma Quilt of Courage #1 - IMF Square
Myeloma Quilt of Courage #1 - Rosemary Rushford
Myeloma Quilt of Courage #1 - Linda Wooten
Myeloma Quilt of Courage #1 - Diane Colon
Myeloma Quilt of Courage #1 - Ann Kaleckas
Myeloma Quilt of Courage #1 - Susan Cann
Myeloma Quilt of Courage #1 - Liz Holz, Barbara Sullivan, Ann Hilario, Carolyn Baker
Myeloma Quilt of Courage #1 - Dorothy Dhesse
Myeloma Quilt of Courage #1 - Barbara Goodfriend
Myeloma Quilt of Courage #1 - Trudy Fobbs 2
Myeloma Quilt of Courage #1 - Cathy Margelewski
Myeloma Quilt of Courage #1 - Nancy Locrecchio
Myeloma Quilt of Courage #1 - Dr. Michael Braver
Congress Moves to Finish Old Business
What's New In Research - January 8, 2003
Myeloma Quilt of Courage #4 - Tom Droege
What's New In Research - January 15, 2003
Thalidomide Insurance Survey
January 16, 2003 Myeloma Minute
January 8, 2003 Myeloma Minute
International Myeloma Foundation - Thalidomide Survey Response
International Myeloma Foundation - Thalidomide Insurance Survey
Myeloma Quilt of Courage #4 - Kathleen McBain
What's New in Research - January 29, 2003
Over 200 people attended the 2003 Los Angeles Patient and Family Interactive Seminar
January 29, 2003 Myeloma Minute
Legal Assistance for the Cancer Patient
Step-by-Step Nutrition Action Plans
Friends We Never Hoped to Meet
Dear Reader
Wamp Swim 2002
Ask the Expert:
Dr. Steve Schey Answers Your Questions
IMF Support Group Leaders? Retreat 2002
Myeloma Center Spotlight: University of Arkansas for Medical Sciences
Reflections on Myeloma ? Past and Future Progress
What's New In Research - February 5, 2003
Fulfilling the Promise of Genomics: Advocates Needed
What's New In Research - February 14, 2003
February 5, 2003 Myeloma Minute
IMF's Multiple Myeloma Quilt of Courage 2
Myeloma Quilt of Courage #2 - Al Fitzgerald
Myeloma Quilt of Courage #2 - Gary E. Schneider
Myeloma Quilt of Courage #2 - Millie Harris
Myeloma Quilt of Courage #2 - Mari Payne
Myeloma Quilt of Courage #2 - Arlene Geczi
Myeloma Quilt of Courage #2 - Patricia Lynn Hansen
Myeloma Quilt of Courage #2 - Jean Willard
Myeloma Quilt of Courage #2 - William V. Herbert
Webcast of Portland Patient & Family Seminar
July 7-8, 2006
Myeloma Quilt of Courage #2 - Craig Louden
Myeloma Quilt of Courage #2 - Forever, Always and Beyond
Myeloma Quilt of Courage #2 - Eva Mathisen
Myeloma Quilt of Courage #2 - David Michael Hahn
IMF Applauds Medicare Decision to Expand PET Scan Coverage for Myeloma
Myeloma Quilt of Courage #2 - The IMF
Myeloma Quilt of Courage #2 - Edward Berry
Myeloma Quilt of Courage #2 - Donald E. Granger
Myeloma Quilt of Courage #2 - Eva Mathisen
Myeloma Quilt of Courage #2 - Hearts & Flowers
Myeloma Quilt of Courage #2 - William V. Herbert
Myeloma Quilt of Courage #2 - Gary E. Schneider
Myeloma Quilt of Courage #2 - Mom
Myeloma Quilt of Courage #2 - Walter Schwartz
Myeloma Quilt of Courage #2 - Frankie Salgado
Myeloma Quilt of Courage #2 - Eva Mathisen
Myeloma Quilt of Courage #2 - Doyle M. Garrett
Myeloma Quilt of Courage #2 - Andre Chabot
Testing polling software
FreeLite Test Measures Free Lambda And Kappa Light Chains In The Blood
What's New In Research - February 19, 2003
Myeloma Quilt of Courage #4 - Mari Susan Payne
February 20, 2003 Myeloma Minute
FUNdraising Made Easy
Congress Supports OVAC Agenda
What's New In Research - February 26, 2003
February 27, 2003 Myeloma Minute
Myeloma Quilt of Courage #4 - Edward J. Berry
What is monoclonal gammopathy of undetermined significance (MGUS)?
March 6, 2003 Myeloma Minute
What's New In Research - March 11, 2003
March 12, 2003 Myeloma Minute
What's New In Research - March 25, 2003
INTERNATIONAL STAGING SYSTEM (ISS)
Gareth J. Morgan, MD
March 26, 2003 Myeloma Minute
IMF: Scientific Advisory Board
IMF 2003 Research Grant Awards
David Roodman, MD
SPREAD THE WORD!
Myeloma Minute
September 19, 2008
Report from the Los Angeles IMF Patient & Family Interactive Seminar
Dear Reader
Ask the Expert: Staying Well During Chemotherapy
Indiana University Cancer Research Center Patient Dinner
A Complementary Approach: Dr. Shlomit Michaely, Ph.D., L.Ac.
Building Bridges: Boston Dedicates A New Bridge To Leonard P. Zakim
Letters
Ferreting for Facts in the Realm of Clinical Trials
Call Congress on April 8 to Support OVAC Agenda
Myeloma Minute - October 9, 2004
What's New In Research - April 4, 2003
April 4, 2003 Myeloma Minute
MAIL FOR THE CURE
International Myeloma Foundation Heralds ECOG Announcement
What is One Voice Against Cancer?
Phase III REVLIMID Clinical Trials
IMF Awards Robert A. Kyle Lifetime Achievement Award to Kenneth C. Anderson, MD
Myeloma Minute - February 1, 2005
Spotlight on Support: A New Group for Long Island, New York
Skeletal Targeted Radiotherapy (STR?)
THE CATLETT CARD SERIES
Webcast: Myeloma Management - New Trends for 2007
Myeloma Minute - February 14, 2006
April 12, 2003 Myeloma Minute
Support Group Leader Retreat
June 27-29, 2003
April 19, 2003 Myeloma Minute
Understanding Revlimid?
Understanding Serum Free Light Chain Assays
Myeloma Minute - January 24, 2006
ASH 2005 Webcast - Combination Therapy With Melphalan, Prednisone and Velcade In Elderly Patients
ASH 2005 Webcast - Update On Neuropathy In Patients On The Velcade APEX Trial
ASH 2005 Webcast - Aplidin For Relapsed/Refractory Myeloma
ASH 2005 Webcast - Phase I Trial Of Atiprimod
ASH 2005 Webcast - Development Of The Custom SNP Chip For BOAC
ASH 2005 Webcast - Combination Therapy With Thalidomide, Velcade And Dexamethasone
ASH 2005 Webcast - Stem Cell Harvesting Using GCSF Alone
ASH 2005 Webcast - Effect Of Velcade Therapy On Markers Of Immune Function
ASH 2005 Webcast - Prophylaxis For Herpes Zoster (Shingles) With Velcade Therapy
ASH 2005 Webcast - Effect Of Velcade Therapy On Markers Of Bone Resorption
ASH 2005 Webcast - Therapy With Velcade And The Radiopharmaceutical Quadramet
New Agents and New Opportunities for Multiple Myeloma Today and Tomorrow
2006 IMF Grant Recipients Honored at Scientific Advisors Meeting
Myeloma Minute - December 23, 2005
Myeloma Minute - March 8, 2006
Special Interview With Julian Adams, Developer Of Velcade
ASH 2005 Webcast - Update On The Velcade APEX Trial For Relapsed Patients
ASH 2005 Webcast - Combination Therapy With Revlimid and Velcade
ASH 2005 Webcast - Genetic Abnormalities Of Patients Dagnosed With MGUS or Smoldering Disease
ASH 2005 Webcast - Combination Therapy With Melphalan, Prednisone and Thalidomide
ASH 2005 Webcast - Combination Therapy With Melphalan, Prednisone and Revlimid
ASH 2005 Webcast - Frontline Therapy With Velcade
ASH 2005 Webcast - Combination Therapy With Melphalan, Prednisone and Thalidomide
IMF LOOKS FORWARD TO RAPID REVIEW OF REVLIMID FOR MYELOMA PATIENTS FOLLOWING FDA APPROVAL FOR MDS
ASH 2005 Webcast - Overview of the IMF's Bank On A Cure Project
ASH 2005 Webcast - SNP Analysis Of Transplant Patients
ASH 2005 Webcast - Combination Therapy With Thalidomide And Dexamethasone In Elderly Patients
ASH 2005 Webcast - Myeloma In Younger Patients
ASH 2005 Webcast - Combination Therapy With Melphalan and Velcade
ASH 2005 Webcast - Combination Therapy With Velcade, Adriamycin and Dexamethasone (PAD)
ASH 2005 Webcast - Gene Expression In Patients Treated With Thal/Dex
ASH 2005 Webcast - Use Of The Free Light Chain Assay (FLC) To Assess Disease And Response
ASH 2005 Webcast - Stem Cell Mobilization With AMD-3100
New! Updated Concise Review 2008/2009
What's New In Research - May 1, 2003
Cancer Research Advocates Must Be Vocal to Reverse Funding Trends
Tim McElwain Travel Grants
May 9, 2003 Myeloma Minute
New Phase II trial opens with VELCADE as front-line therapy
June 11, 2003 Myeloma Minute
Myeloma Minute Special Edition- FDA Approves Velcade for Myeloma Treatment
What's New In Research - May 16, 2003
May 16, 2003 Myeloma Minute
IXth International Myeloma Workshop: Friday, May 23rd, 2003
Conceptos Breves Sobre La Enfermedad Y Las Opciones Terapéuticas Mieloma Múltiple Cáncer De La Médul
IMF's Multiple Myeloma Quilt of Courage 3
What's New In Research - October 13, 2003
Myeloma Quilt of Courage #3 - Leslie Cohen
Myeloma Quilt of Courage #3 - Tracy Wright
Myeloma Quilt of Courage #3 - Barbara Jewell
Myeloma Quilt of Courage #3 - Christine Meeks
Myeloma Quilt of Courage #3 - Susan Emery
Myeloma Quilt of Courage #3 - Samara E. Krugman
Myeloma Quilt of Courage #3 - Patricia Wascher
Myeloma Quilt of Courage #3 - Jeanne Bechtel
Myeloma Quilt of Courage #3 - Harriet Bertsche
Myeloma Quilt of Courage #3 - Hal Gleason
Myeloma Quilt of Courage #3 - Judy Van Schoyck
Myeloma Quilt of Courage #3 - Anna Cazale
Myeloma Quilt of Courage #3 - Pat Hall
Myeloma Quilt of Courage #3 - Isabelle Weinberg
Myeloma Quilt of Courage #3 - Anne Heutlinger
Myeloma Quilt of Courage #3 - Lynn Betts
Myeloma Quilt of Courage #3 - Kim Patocka
Myeloma Quilt of Courage #3 - Laura Schultz
Myeloma Quilt of Courage #3 - Keith Garber and Amanda Frantzen
Myeloma Quilt of Courage #3 - Delfina Theimer
Myeloma Quilt of Courage #3 - Vanessa Bernstein
Myeloma Quilt of Courage #3 - Christine Storms
Myeloma Quilt of Courage #3 - Serafin Salgado
Myeloma Quilt of Courage #3 - Samona Creasy
Myeloma Quilt of Courage #3 - The IMF
May 25, 2003 Myeloma Minute
ESTADIFICACI?N Y CLASIFICACI?N PRON?STICA
TRATAMIENTO INICIAL O DE PRIMERA L?NEA
TRATAMIENTO DE SOPORTE
FRACASO DEL TRATAMIENTO DE PRIMERA L?NEA
PREGUNTAS PARA HACERLE A SU DOCTOR
Guia Para el Paciente 2003 - T?RMINOS Y DEFINICIONES
IXth International Myeloma Workshop - Saturday, May 24th, 2003
IXth International Myeloma Workshop - Saturday, May 24th, 2003 - Genetic Heterogeneity
IXth International Myeloma Workshop - Sunday, May 24nd, 2003 - International Support Group Meeting
IXth International Myeloma Workshop - Sunday, May 25th, 2003
IXth International Myeloma Workshop - Monday, May 26th, 2003
Guia Para el Paciente 2003 - T?RMINOS Y DEFINICIONES
Guia Para el Paciente 2003 - T?RMINOS Y DEFINICIONES
IXth International Myeloma Workshop - Sunday, May 25th, 2003 - Gala Dinner and Spanish Fiesta
IXth International Myeloma Workshop - Saturday, May 24th, 2003 - Support Group Meeting
IXth International Myeloma Workshop - Sunday, May 25th, 2003 - Prognostic Factors
IXth International Myeloma Workshop - Saturday, May 24th, 2003 - From MGUS to Myeloma
IXth International Myeloma Workshop - Poster Sessions
IXth International Myeloma Workshop - Monday, May 26th, 2003 - Chemotherapy And Maintenance
The Role of Thalidomide in Myeloma Treatment
Jack Aiello
IXth International Myeloma Workshop - Monday, May 26th, 2003 - Autologous Transplantation
IXth International Myeloma Workshop - Monday, May 26th, 2003 - Tandem Autologous Transplantation
IXth International Myeloma Workshop - Monday, May 26th, 2003 - Auto Transplant Special Situations
IXth International Myeloma Workshop - Monday, May 26th, 2003 - Mini-Allo Transplantation
Open Thalomid (thalidomide) Clinical Trials
Phase I/II THALOMID® Clinical Trials
Phase II THALOMID® Clinical Trials
Phase II/III THALOMID® Clinical Trials
Phase IV THALOMID® Clinical Trials
Phase III THALOMID® Clinical Trials
IXth International Myeloma Workshop - Monday, May 26th, 2003 - High Dose Therapy Concluding Remarks
IXth International Myeloma Workshop - Tuesday, May 27th, 2003 - Novel Therapies, Part I
Comprehensive Guide to Salamanca: Understanding the IX Myeloma Workshop - May 23-27, 2003
IXth International Myeloma Workshop - Tuesday, May 27th, 2003 - Novel Therapies, Part II
IXth International Myeloma Workshop - Tuesday, May 27th, 2003
IMFer Mike Katz Receives Award For Work As An FDA Patient Consultant
What's New In Research - June 10, 2003
June 19, 2003 Myeloma Minute
MYELOMA BONE DISEASE ? UPDATE 2003
The Myeloma Matrix Part II (Phase I -> Phase I/II)
BOTTLES FOR GRANDPA
Food And Drug Administration - Oncologic Drugs Advisory Committee Meeting (March 4, 2005)
Updates from Bank On A Cure
Bank On A Cure Launch: IMF Launches World?s First DNA Database for Myeloma Patients
Bank On A Cure Launch: About the International Myeloma Foundation
Bank On A Cure? Launch: Bank On A Cure? Questions & Answers
Bank On A Cure? Understanding Multiple Myeloma
Bank On A Cure Launch: Frequently Asked Patient Medical Questions
AMEN - The Israeli Association of Myeloma Patients
ACRONYMS
Cancer Trials Support Unit (CTSU)
Myeloma Quilt of Courage #4 - Calvin Lamont Tidwell
Report from the Hope & Trust Meeting at the Royal College of Physicians
REVIS?O RESUMIDA DO MIELOMA E DAS OP??ES DE TRATAMENTO
Profile Interview: Julian Adams, Ph.D.
FDA Approves VELCADE® for the Treatment of Relapsed and Refractory Multiple Myeloma
Dear Reader
Life Lessons from a Politician
Letters
News & Notes
Myeloma Update
Q&A: Get Your Questions Answered
Celgene?s Revlimid? (lenalidomide) Exceeds Expectations in Relapsed and Refractory Myeloma
Myeloma Awareness Week 2003 - August 10-17
June 28, 2003 Myeloma Minute
Congressional Appropriations Committees Act: Senate Approves Funding for Ferraro Education Program
What's New In Research - July 17, 2003
July 18, 2003 Myeloma Minute
?CRAB? Crawls Into Importance
Myeloma Quilt of Courage #4 - Cathy Eggers Golden
Phase II Multicenter Open Label Study of Single-Agent REVIMID
July 26, 2003 Myeloma Minute
What's New In Research -August 2, 2003
August 2, 2003 Myeloma Minute
Myeloma Quilt of Courage #4 - Vincent Faber
Report from the Robert Kyle Lifetime Achievement Awards Dinner
August 9, 2003 Myeloma Minute
Team Goes to Bat for Coach's Brother and the IMF
Szpiczak mnogi ? poradnik dla lekarzy
Advocates Needed to Contact Congress to Increase Medical Research Funding
What's New In Research - August 17, 2003
IMF Japan Petitions The Ministry Of Labor & Welfare for Approval of Thalidomide and Velcade
August 18, 2003 Myeloma Minute
Special Jewelry Discounts for IMF Members
What's New In Research - August 22, 2003
August 24, 2003 Myeloma Minute
Ask the Expert: The use of DOXIL? in multiple myeloma
Myeloma at the Movies Lending Library
Saluting an Incredible Human Being:
Dr. Robert A. Kyle Receives Lifetime Achievement Award
THALIDOMIDE
IMF's Multiple Myeloma Quilt of Courage 4
Myeloma Quilt of Courage #4 - Just Jax
Myeloma Quilt of Courage #4 - Marge Harnage
Funding and Medicare Issues Still Debated by Congress
September 4, 2003 Myeloma Minute
?Necesitamos su ayuda!
What's New In Research - September 12, 2003
Senate Fails to Pass Amendment to Increase Research Funds
September 14, 2003 Myeloma Minute
What's New In Research - September 21, 2003
Understanding Thalidomide Therapy
Myeloma Minute - February 7, 2006
Comprendre le traitement ? la thalidomide
Understanding Trisenox® (arsenic trioxide) injection
КРАТКИЙ ОБЗОР ЗАБОЛЕВАНИЯ И ВОЗМОЖНОСТЕЙ ЛЕЧЕНИЯ
МНОЖЕСТВЕННАЯ МИЕЛОМА РАК КОСТНОГО МОЗГА
Myelom Merkur - Ausgabe, November 2006
Una explicaci?n de la Terapia con Talidomida
Understanding Dexamethasone and Other Steroids
Carol & Benson Klein, Dinner Chairs
House Budget Committee is Next Funding Hurdle
Myeloma Minute - March 29, 2006
Thalidomid verstehen

PET Scan Coverage Moving Forward
September 22, 2003 Myeloma Minute
Opuscolo informativo sulla terapia con talidomide
Das Handbuch zu Dexamethason und Steroidtherapie
Dexamethason und Steroidtherapie
verstehen



Report from the Kyoto Seminar 2005
The IMF?s Debbie Birns Visits AMEN
Tom Bay, Noted Author and Motivational Speaker, joins IMF Board of Directors
Conociendo la Cifoplastia con Bal?n y las Fracturas Vertebralescon Aplastamiento producidas por el Mieloma
October 15, 2003 Myeloma Minute
Rockin' the Night Away!
The Ribbon of Hope Gala in Seattle 2003
October 24, 2003 Myeloma Minute
Fiesta for a Cure! - Silent Auction Items
Fiesta for a Cure! - Prizes
Breve Relazione della malattia e delle opzioni terapeutiche
Mieloma Multiplo Tumore del midollo osseo
Conoscere e capire il dosaggio delle Catene Leggere Libere nel Siero

High-Dose Melphalan in the Era of New Effective Agents
The Potential Role of Novel Combinations in Frontline Therapy
The Importance of Achieving Complete Remission (CR
Does the Percentage of Complete Response with New Drugs Determine Ultimate Survival?
The Safety Issue Surrounding Maintenance Therapy
Myeloma Minute - June 20, 2004
Have an Old Cell Phone?
Turn It Into Dollars for a Cure
Does Maintenance Therapy Improve Time to Progression and Ultimate Survival?
Is Double Transplant Better Than Single Transplant?
Tandem vs Single Transplant: Which is Better for Whom?
Role of New Drug Trials at Relapse
IMF Research Grant Summary (1995-2004)
Myeloma Quilt of Courage #4 - Frankie Salgado
Myeloma Quilt of Courage #4 - Frankie Salgado
What's New In Research - November 1, 2003
November 1, 2003 Myeloma Minute
Medicare Proposals Threaten Access to Care
Appropriations Update
November 9, 2003 Myeloma Minute
Concise Review 2003 - Japanese Edition
Revue de la Maladie et des Options Therapeutiques
Dear Reader
News and Notes
Ask the Expert:
The Pathogenesis and Treatment of Multiple Myeloma Bone Disease
IMF Support Group Leader Retreat
The Good, the Bad, and the Ugly of Cancer Public Policy
IMFer Profile: Terry Herman Shares Her Story
Scientific Advisor Profile: Meet New Members of the IMF Scientific Advisory Board
Rafael Fonseca, M.D.
John Gibson, M.D., Ph.D.
Kazuyuki Shimizu, M.D.
Jan Westin, M.D., Ph.D.
She's Banking on Finding a Cure
Congressional Conferees Move Closer to Medicare Agreement
Write to Congress
Phase II REVLIMID? Trials
November 16, 2003 Myeloma Minute
The IMF Visits Italy and France
Myeloma Patients and Oncology Nurses to Benefit from IMF/Millennium Collaboration
Veterans, Agent Orange, Multiple Myeloma, and VA Benefits
It?s Your Attitude... It?s Your Choice
Early studies indicate targeted radioactive drug may expand treatment options for myeloma
Letters
News and Notes
Medicare and Appropriations Bills Threaten to Leave Most Cancer Patients Behind
What's New In Research - November 24, 2003
The Gift of Giving
November 26, 2003 Myeloma Minute
Eric Vogt
Valerie Holloway
Charles "Chuck" Thompson
Steven Howell
Jacklyn Inman
Robert Heeren
Lorna Newlin
Pennie Lawrence
Marvin Mason
Ralph D'Errico
2004 Research Grants Awarded to the Best
IMF Announces Key Worldwide Funding
OVAC Urges the Senate to Support Funding Increases to Cancer Research and Program Funding!
Opening of National Oncologic PET Registery Hits Snag.
Confusing news stories about the efficacy of thalidomide. What does this all mean?
Past Recipients of the Robert A. Kyle Lifetime Achievement Award
Robert A. Kyle Lifetime Achievement Award
IMF PRESENTS THE KYLE LIFETIME ACHIEVEMENT AWARD TO MARIO BOCCADORO, MD, OF THE UNIVERSITY OF TORINO, ITALY
Sponsorship Opportunities for the Fourth Annual Robert A. Kyle Lifetime Achievement Award
Reporte desde Madrid
Understanding Bisphosphonate Therapy
Why Should I Attend an IMF Patient & Family Seminar? Testimonials
NIH Announces Program to Foster the Independence of New Investigators
Multiple Strategies for Treating Myeloma: Case Discussions
Elise Segar and Red Dot Match Funds for the IMF
Myeloma Minute - February 1, 2006
Thank You IMFers
In Search Of The Myeloma Stem Cell: A Special Report
ASH 2003: An Avalanche of New Information
What does it all mean, and where do we go from here?
What's New In Research - December 22, 2003
December 23, 2003 Myeloma Minute
Phase I VELCADE® Clinical Trials
You are now leaving the IMF website and are accessing the Ortho Biotech homepage.
WAITING
Understanding VELCADE® (bortezomib) for Injection Therapy
New opportunity for American Express Cardholders to support IMF
VELCADE® (bortezomib) for Injection
testing google free search
January 20, 2004 Myeloma Minute
Advocacy Update: Federal Support for Cancer Issues in Decline
Did You Know?
Immunizations in myeloma patients
Medicare Changes Impact Care
Senate Passes Funding Bill; Includes Money for Myeloma Community
2nd Annual Cancer Survivorship Telephone Education Workshop Series, Cancer Survivorship
January 29, 2004 Myeloma Minute
PRESS OFFICE
MEDIA ALERT - MINNEAPOLIS PATIENT & FAMILY SEMINAR
February 26, 2004 Myeloma Minute
Message from IMF President
Advocacy Update: Congress Adjourns
News and Notes
Report from the Sixth Annual Support Group Leaders' Retreat
July 8-10, 2005
Ask the Expert: What's New with the Use of VELCADETM in MM?
Who is the Unknown Patient?
Did You Know?
Important New Blood Cancer Initiative Announced on Capitol Hill
CTSU Independent Clinical Research Site (CICRS) Initiative
IMF Christmas Cards With Original Jr. IMFer Art
Drug Compendia List Revlimid for Frontline Treatment of Myeloma
Report from the Inaugural IMF - China Myeloma Symposium
October 20, 2007 in Beijing, China.
Myeloma Minute - November 6, 2007
Myeloma Minute - June 9, 2005
Die Bisphosphonat-Therapie verstehen
Una explicaci?n de la Terapia con Bisfosfonatos
Comprendre la Therapie aux Bisphosphonates
Mieux Connaître VELCADE® (bortézomib) pour Injection 2006
Program Highlights from the 10th International Workshop in Myeloma
The Myeloma Matrix Part III (Pre-Clinical)
Webcasts from IMF Patient & Family Seminar in Torino, Italy
Celebrating a Life
Torino Myeloma Conference
April 22, 2004
Torino Myeloma Conference
April 23, 2004
Torino Myeloma Conference
April 24, 2004
IMF Receives Million Dollar Grant from Centers for Disease Control and Prevention
Myeloma Minute: Important News from Washington
Celebrating a Life: IMFer Gerry Difford
Myeloma Minute: Special Advisory On Osteonecrosis Of The Jaws
The IMF Advocates Formal Approval of Thalomid(R) for Myeloma
Myeloma Minute - May 21, 2004
Update From ASCO 2004: Vincent Rajkumar, MD, Mayo Clinic, Rochester, MN
Update From ASCO 2004: Ivan Borrello, MD, Johns Hopkins University, Baltimore, MD
Paul Richardson, MD, Dana Farber Cancer Institute, Boston, MA
William Matsui, MD, The Myeloma Stem Cell
International Myeloma Foundation Heralds ECOG Announcement
BLTD Protocol
Morton Coleman, MD, Weill Medical College, Cornell University, New York, NY
Brian G.M. Durie, MD, Cedars Sinai Medical Center, Los Angeles, CA
Sundar Jagannath, MD, St. Vincents Comprehensive Cancer Center, New York, NY
Sundar Jagannath, MD, St. Vincents Comprehensive Cancer Center, New York, NY
Robert A. Kyle, Mayo Clinic, Rochester, MN
Jamie Cavanagh, St. Bartholomew's Hospital, London, UK
William Bensinger, MD, Fred Hutchison Cancer Research Center, Seattle, WA
William Bensinger, MD, Fred Hutchison Cancer Research Center, Seattle, WA
Gareth Morgan, MD, Leeds General Infirmiry, Leeds, UK
Mohamad A. Hussein, MD
Leader, Multiple Myeloma Clinical Research
H. Lee Moffitt Cancer & Research Institute
Tampa, Florida
testing verisign seal
Report from Tokyo 2004 Patient and Family Seminar
MYELOMA MINUTE SPECIAL EDITION - REPORT FROM ASCO 2004
testing
IMF
Antonio Palumbo, MD, of The Italian Multiple Myeloma Study Group
test
A. Palumbo, MD, The Italian Multilple Myeloma Study Group
Antonio Palumbo, MD, of The Italian Multiple Myeloma Study Group
Robert M. Rifkin, MD, Rocky Mountain Cancer Centers, US Oncology, Denver, CO
Fighting Myeloma at Sea!
IMF's Centers for Disease Control and Prevention (CDC) grant renewed for second year
Advocacy Update: Support for Cancer Priorities Short-Changed in President?s Budget
Understanding Stem Cell Transplant
MULTİPL MİYELOM
Phase III VELCADE® Clinical Trials
Phase I/II VELCADE® Clinical Trials
Myeloma Minute - January 19, 2004
Fighting Myeloma at Sea! - Jerry Eisenhower's Maritime Journal
MYELOMA MINUTE SPECIAL UPDATE:
THALIDOMIDE TO BE COVERED IN MEDICARE DEMONSTRATION PROJECT
Online Support Group -- a.k.a., the ListServ
BERMUDA :?THE 3RD IMF SCIENTIFIC ADVISORS RETREAT
Focus on Molecular Testing and Clinical Trials
Report from ASCO 2004: MYELOMA FRONTLINE THERAPY IN THE SPOTLIGHT
Aredia/Zometa and osteonecrosis of the jaws
A New Update - July 2004
Myeloma Manager™ News
THE INTERNATIONAL MYELOMA FOUNDATION SAYS REVLIMID? MEETS IMPORTANT QUALITY OF LIFE MEASURES
THE INTERNATIONAL MYELOMA FOUNDATION SAYS NEW TREATMENT REGIMEN FOR OLDER PATIENTS COULD SOON BE APPROVED IN EUROPE
Major Medical Conference Points to Improved Treatment and Survival Options for Blood Cancers
KOS 2007: International Staging System for Multiple Myeloma
KOS 2007: Prognostic Factors for Multiple Myeloma in the Era of Novel Therapies
International Myeloma Foundation Supports Senator Hutchison Initiative
Greetings from Australia
Pictures from the Philadelphia Patient and Family Seminar - October 17-18, 2003
Myeloma Minute - July 27, 2004
14th Anniversary Ribbon of Hope Gala Honorees
14th Anniversary Ribbon of Hope Gala Sponsors
14th Anniversary Ribbon of Hope Gala Honorees:
COURAGE AWARD
14th Anniversary Ribbon of Hope Gala Honorees:
GUEST OF HONOR
14th Anniversary Ribbon of Hope Gala Honorees:
VISIONARY AWARD
Pictures from the San Jose Patient and Family Seminar
July 16-17, 2004
Medicare eligible? Apply NOW to save 90% of thalidomide costs!
Myeloma Minute - August 2, 2004
Myeloma Minute - July 27, 2004
Third Annual Myeloma Awareness Week (August 20 -30)
IMF Raises Awareness of little known Cancer
Michio M. Kawano, MD
QUARTERLY UPDATE FROM BANK ON A CURE?
February 2004
IMPORTANT INFORMATION ABOUT THE MEDICARE DEMONSTRATION PROGRAM
QUARTERLY UPDATE FROM BANK ON A CURE?
Summer 2004
First Myeloma-Specific Cancer Patient DNA Bank Becomes a Reality
Special Myeloma Minute: Medicare eligible? Apply NOW to save 90% of thalidomide costs!
Myeloma Minute - August 18, 2004
I'm Not Leavin'
by Michael Tuohy
IMF Welcomes Multiple Myeloma Research Consortium to Team
The IMF at Work in Washington
IMF Urges Medicare to Add Thalidomide to Demonstration Project
IMF Receives Million Dollar Grant from Centers for Disease Control and Prevention
14th Anniversary Ribbon of Hope Gala Auction
14th Anniversary Ribbon of Hope Gala Auction - Travel
14th Anniversary Ribbon of Hope Gala Auction - Entertainment
Applications to Medicare Demonstration Project Far Below Expectations
CMS May Limit Off-Label Coverage For Cancer Drugs To Clinical Trials
The IMF Presents the 2nd Annual Myeloma Awareness Week
Myeloma Minute - September 30, 2004
International Myeloma Foundation Privacy Statement
Guide to Drug Names
IMF WALL OF MIRACLES
A Comprehensive Guide to Torino Multiple Myeloma 2004 Conference
Antonio Palumbo, MD, of The Italian Multiple Myeloma Study Group
Myeloma Minute - October 17, 2004
Jayesh Mehta, MD
What would be the significance of FDA Approval of Thalidomide for Myeloma?
Myeloma Minute - October 26, 2004
The Benefits of Adding Thalidomide to a DVd Regimen
REPORT FROM THE 14th ANNIVERSARY RIBBON OF HOPE GALA
San Diego Patient & Family Seminar a Sold Out Success
14th Anniversary Ribbon of Hope Gala Honorees:
RIBBON OF HOPE AWARD
IMF "Ask the Expert" Video: Donna Weber, MD
M.D. Anderson, Houston, TX
CITINGS
ASH 2004 Webcast
Myeloma Minute - December 3, 2004
YOUR IMF DOLLARS AT WORK
CURRENT U.S. EXPERIENCE WITH TRANSPLANTATION AND MANAGEMENT OF THE NEWLY DIAGNOSED PATIENT
OVERVIEW OF KYPHOPLASTY IN THE MANAGEMENT OF SPINAL TUMORS
APEX
PAD COMBINATION THERAPY FOR PREVIOUSLY UNTREATED PATIENTS
EVALUATION OF THE PATIENT IN INITIAL RELAPSE AND SELECTION OF SECOND-LINE THERAPEUTIC OPTIONS
OSTEONECROSIS OF THE JAWS IN MYELOMA:
Time Dependent Correlation with AREDIA and ZOMETA Use
NEW APPROACHES TO MYELOMA STAGING AND FRONT-LINE TREATMENT SELECTION
New, Improved Staging System for Multiple Myeloma Developed for Use Around the World
PRELIMINARY CASE EVALUATION: AN INTERACTIVE ASSESSMENT OF AUDIENCE TREATMENT OPTIONS
SUPPORTIVE CARE AND THE MANAGEMENT OF THE NEWLY DIAGNOSED AND INITIALLY RELAPSING PATIENT
CURRENT EUROPEAN EXPERIENCE WITH TRANSPLANTATION AND MANAGEMENT OF THE NEWLY DIAGNOSED PATIENT
CONTROVERSIES IN MYELOMA MANAGEMENT
Diagnosis, Initial Treatment and the Relapsing Patient
Primary Treatment with Pulsed MDT in Symptomatic Elderly Patients
Pilot Study Evaluating the Safety & Efficacy of AMD3100 ...
Randomized Trial Comparing MP, MP-THAL and MEL100 for Newly Diagnosed Pts Aged 65-75 Years
ECOG Clinical Trials in Myeloma For Newly-Diagnosed Patients
Fonseca
Antibody-Based Therapy Targeting Myeloma Stem Cells
A Phase I, Multi-Dose Study of SGN-40 (anti-huCD40 mAb) in Patients with MM
Bortezomib as First-Line Therapy in Patients with MM; A Multicenter Phase 2 Clinical Trial
DEVELOPMENT, PREDICTION, AND TREATMENT OF ANEMIA IN PATIENTS WITH LYMPHOMA/MM
Depsipeptide in the Treatment of Relapsed and Refractory MM: A Prospective Evaluation
MPT vs MP: INTERIM ANALYSIS PROSPECTIVE RANDOMIZED TRIAL NEWLY DIAGNOSED PATIENTS AGE > 65 YEARS
A Randomized Phase III Trial of Thal/Dex vs Dex in Newly Diagnosed MM (E1A00)
Phase 2 Trial of Single Agent Bortezomib in Patients with Previously Untreated Multiple Myeloma
Bortezomib Vs High-Dose Dexamethasone in Relapsed MM: Results of a Large Randomized Phase 3 Study
Phase I/II Nat'l Open-label Study of Bortezomib + Melphalan + Prednisone in Elderly Untreated MM Pts
Poorer Survival in Multiple Myeloma Correlates with Patients? Age...
THAL + DEX IS EFFECTIVE SALVAGE REGIMEN FOR PTS RELAPSING AFTER AUTOLOGOUS TRANSPLANT
Siegel
Sundar Jagannath, MD
VTD (Velcade, Thalidomide, Dexamethasone) as Primary Therapy for Newly-Diagnosed Multiple Myeloma.
Rodriguez ASH
[4869] IL-101082-A and TNF-Alpha 238/308A Genotypes Associated with Earlier (< 55) Onset of MM
REPORT FROM THE IMF- AND ICHE-SPONSORED
CONTROVERSIES IN MYELOMA MANAGEMENT
Clin. implications of t(11;14)(q13;q32), t(4;14)(p16;q32) and -17p13 (p53) deletions in pts with HDT
IMFer Michael Katz Receives Certificate of Appreciation from National Cancer Institute
CASE EVALUATION REVISITED
International Myeloma Foundation (IMF) to Bring Highlights from Prestigious International Myeloma Wo
Message from IMF President
Why Bank On A Cure??
Treating Multiple Myeloma: The Little Rock Approach
The Genetics of Multiple Myeloma
Drug Resistance: Overcoming Multiple Myeloma Drug Resistance by Inhibiting the Proteasome
Education Initiative
Atiprimod: A New Drug Candidate in Early-Stage Development for Myeloma
Cancer Research and Medicare: Political Pork?
IMF Kicks Off 2004 Seminars with Florida Retreat
Los Angeles Area Support Group Salutes Leader
IMFers Pay Tribute To Janet Johnson
International Myeloma Foundation Celebrates Landmark Success of 2004
One Voice Against Cancer
Letter to President Bush
One Voice Against Cancer Lobby Day
Spotlight on The Myeloma Foundation of Australia
Federal Cancer Policy: The Big Picture and its Consequences
The IMF Latin America
Myeloma Minute - February 10, 2005
Did You Know?
The Gift of Good Nutrition
Ask the Expert: Thalidomide and the ImiDs
Research Progress Report: Dr. Ivan Van Riet
YOUR GIFTS AT WORK: 2003 Brian D. Novis Research Grant Awards
News & Notes
My New First Birthday
IMF Receives Four-Star Rating from America's Largest Charity Evaluator
Man raises awareness of myeloma: Profile of Peter Tischler
Myeloma Minute - March 20, 2005
Dallas 2005 Patient & Family Seminar
Myeloma Minute - Coming to a City Near You!
Charity Navigator Gives IMF Highest Rating Available
IMFers Share Their Thoughts
Patient Perspective: Tracking My Numbers
Patient Perspective: My New First Birthday
Message from the IMF President
ASH 2004: The Avalanche of Information Continues
New Developments in Multiple Myeloma
The Expanding Role of Proteasome Inhibition in Multiple Myeloma
IMFer Profile: Andy Lebkuecher
Meet the New IMF Director of Support Groups
News & Notes
North Texas MM Support Group
Myeloma Minute Special Edition: Important VELCADE® News
Katie's Birthday
The Touching Story of a Little Girl's Love
Sydney 2005:
Welcome
Sydney 2005:
Unconventional Switched Bone Marrow Plasma Cells with Ig V-region Mutations
Sydney 2005:
Cell Cycle Control of Multiple Myeloma Pathogenesis
Sydney 2005:
Cross-talks Between Plasma Cells and the Microenvironment: Triggering and Targeting
Sydney 2005:
Immunophenotype of the Malignant Clone ? Implications on Management
Sydney 2005:
Clinical and Biologic Implications of Genomics in Myeloma
Sydney 2005:Pathogenic Events Identified by Chromo. Translocations & Cyclin D Exp. Determine Myeloma
Sydney 2005:
Pathogenesis of Myeloma: Ig Translocations, Cyclin D Dysregulation, Other Events
Sydney 2005:
Epigenetic Changes in the Molecular Pathology of Multiple Myeloma
Sydney 2005:
Alternative Gene Splicing in Myeloma; Aberrant Splicing of Hyalur.
Sydney 2005:
Is Thalidomide First Line Therapy?
Sydney 2005:
Thalidomide and Cardiovascular Complications in MM
Sydney 2005: Opening Ceremonies
Sydney 2005:
New Advances in the Management of Myeloma Bone Disease
Sydney 2005:
Plasmapheresis in Renal Failure
Sydney 2005:
Prevalence, Pathogenesis & Treatment of Anemia with Erythropoetic Agents in MM
Sydney 2005:
Epidemiology of Multiple Myeloma
Sydney 2005:
Smoldering MM: Criteria for Diagnosis & Results of Long-Term Follow-Up
Sydney 2005:
The Evolving vs Non-Evolving Nature of Asymptomatic Monoclonal Gammopathies
Sydney 2005:
The International Staging System for Myeloma: An Update
Sydney 2005:
Advances in Diagnosis and Imaging in MM
Sydney 2005:
Normal Plasma Cell Development and Pathogenesis of MGUS and MM
Sydney 2005:
Cell. Model for MM Cell Growth & Differentiation Based on Intra-clonal CD45 Microenv
Sydney 2005:
Intercellulalar Communication Signals Determined by Gene Expression Profiling in MM
Sydney 2005:
The Funcation and Movement of CD45 Molecule in IL6-induced MM Cell Expression
Sydney 2005:
Maintenance Therapy After Autologous Stem Cell Transplantation: IFM99 Trial
Sydney 2005:
What Have the Transplant Registries Taught Us?
Sydney 2005:
HDT Options for Elderly Myeloma Patients: Results of a Randomized Controlled Trial
Sydney 2005:
Total Therapy for Newly Diagnosed MM: the Arkansas Experience
Sydney 2005:
Is Double Autograft the Standard of Care?
Sydney 2005:
Pathogenesis of Myeloma Bone Disease
Sydney 2005:
Osteoblast Function in Myeloma (endothelin 1, osteoblast proteosome)
Sydney 2005:
Bisphosphonates and the Bone Microenvironment
Sydney 2005:
Mouse Model in Tumour Microenvironment and Bone Disease
Sydney 2005: Bortezomib - A First in Class Proteasome Inhibitor & Important Advance in the Tx of MM
Sydney 2005:
Lenalidomide (CC-5013, Revlimid?) and Other IMiDs
Sydney 2005: Pegylated Doxorubicin in Combination w Immune-modulators & Arsenic
Sydney 2005:
Overview of New Therapies and Future Directions
Sydney 2005:
The Influence of the Tumour Microenvironment on Drug Response & Drug Resistence
Sydney 2005:
Angiogenesis in Myeloma - An Overview
Sydney 2005:
New Antiangiogenic Agents
Sydney 2005: Targeting of VEGF and PDGF Signaling by Receptor Tyrosine Kinase Inhibitors Impairs...
Sydney 2005: Molecular Mechanism Involved in Homing and Migration of Plasma Cells to the Bone Marrow
Sydney 2005:
Mechanisms of Oncogenesis in Waldenstrom's Macroglobulinemia
Sydney 2005:
Novel Insights into the Biology & Therapy of Waldenstrom's Macuglobulinemia
Sydney 2005:
Treatment of Waldenstrom's Macroglobulinemia
Sydney 2005:
Amyloidosis
Sydney 2005: Cryoglobulinaemia, POEMS and Gammopathy Associated Neuropathy
Professor Jean-Luc Harousseau Receives Prestigious Waldenstrom Award for a Lifetime of Achievement
Daily Update from International Myeloma Workshop - April 11, 2005
Myeloma Minute - February 28, 2006
Sydney 2005: In MM 14q32 Transloc. are Present in Memory B Cells but RAS Mutations are Restricted...
Daily Update from International Myeloma Workshop - April 12, 2005
Sydney 2005: Phase I Study of Velcade with Revlimid in Relapsed and Refractory MM: The RevVel Study
Daily Update from International Myeloma Workshop - April 13, 2005
Daily Update from International Myeloma Workshop - April 14, 2005
Sydney 2005: The Transcriptome of MM Defines Disease Subgrps w/ Distinct Genetic & Clinical Features
Sydney 2005:
Translocation (4:14), Fibroblast Growth Factor Receptor 3 (FGFR3) and MM
Sydney 2005:
The Pharmacogenomics of Myeloma
Sydney 2005: Associations of Genetic Variation with Clinical Outcome: Update on Bank On A Cure
Sydney 2005: Microarray Exp. Profiling Indicates Upreg. of Ribosomal Machinery in del(13)-Neg Clone
Sydney 2005: Intensive v Double Intensive Tx in Untreated MM: Update of HOVON 24 MM
Sydney 2005: Single v Double HDT in MM: Second Analysis of the Trial GMMG-HD2
Sydney 2005: HDT / Stem Cell Support in MM: Update of the Spanish Studies (PETHEMA/GEM)
Sydney 2005: Double v Single ASCT & Role of Added Thal as First-line Tx for MM (Bologna 96 and 02)
Sydney 2005:
Update on High Dose Therapy: MAG Studies
Sydney 2005:
Update on High Dose Therapy: MRC Studies
Sydney 2005:
New Therapeutic Approaches in Myeloma Bone Disease
Sydney 2005: MIP-1a: Osteolytic & Tumour-Promoting Effects in MM Bone Disease
Sydney 2005:
RANK and MIP-1alpha in MM: Clinical Implications
Sydney 2005: Toward the Elucidation of the Role of Altered Wnt Signaling MM
Sydney 2005:
MIP-1 May Cause Reciprocal of Osteoclast and Dendritic Cell Diff. from Monocytes
Sydney 2005:
State of the Art of Allogenic Transplantation in MM
Sydney 2005:
What is the Role of Reduced Intensity Allogeneic Stem Cell Transplantation?
Sydney 2005:
High Dose or Reduced Intensity Conditioning for MM?
Sydney 2005: Strategies to Improve the Graft v MM Effect of Allo SCT & Donor Lymphocyte Infusions
Sydney 2005:
Efficacy of a 2nd Transplant with a 1st ASCTResults from a Spanish PETHEMA/GEM Study
Sydney 2005:
Bone Marrow Homing of MM Cell
Sydney 2005:
Role of the IGF-1/IGF-1 Receptor Pathway in the 5TMM Experimental Mouse Model
Sydney 2005:
AKT in MM: Therapeutic Implications
Sydney 2005: In MM Cells, Birn Pro-Apoptotic Functionis Neutralized Thru Endogenous Mcl-1/Birn ...
Sydney 2005: Inhibition of MM Cell Proliferation & Increase of Apoptosis thru Reg. of NF-kB & JNK...
Sydney 2005: Human Apurinic/Apyrimidinic Endonucleases (Ape1 & Ape 2) Leads to Genetic Instability
Sydney 2005: Bone Marrow Microvessel Endothelial Cells in MM Harbor MM-Assoc. Chromosomal Transloc.
Sydney 2005:
Coexpression of CD11a and CD45bright is the Hallmark of Proliferating Cell Malig.
Sydney 2005:
Bcl-xl, Myc, and Mutant Ras Transgenic Mouse Models of Plasma Cell Malignancies
Sydney 2005:
Final Results of IFM9904 Protocol: Dbl. Transplant +/- anti-IL6 Mono. Antibody in..
Sydney 2005: 1st Interim Analysis of Joint HOVON-GMMG-HD3 Randomised Study
Sydney 2005: Interim Analysis of the IFM 99-06 Trial on 350 Patients
Sydney 2005:
Tumor Immune Interactions in Myeloma
Sydney 2005:
T Cells in Myeloma: Lessons from a Murine Model
Sydney 2005:
Dendritic Cell Biology in Multiple Myeloma
Sydney 2005: Phenotypic and Functional Alterations of Gamma/Delta T Cells in Myeloma
Sydney 2005: The Role of Dendritic Cell Genotype in the Induction of T-Cell Responses...
Sydney 2005: A Phase I, Multi-Dose, Dose Escalation Study of SGN-40 (anti-huCD40 mAb) ...
Sydney 2005: Antagonist Anti-CD40 antibody CHIR-12.12 Causes Tumour Regr. & Prolongs Survival in MM
Sydney 2005: CHIR-258, a Novel Multi-Targeted Tyrosine Kinase Inhibitor, for the Tx of t(4;14) MM
Sydney 2005: Targeting the Insulin-Like Growth Factor-I Receptor (IGF-IR) in MM Cells ...
Sydney 2005: In Vitro Activity of a Novel Small Molecule Cyclin Dependent Kinase inhibitor, CYC202..
Sydney 2005: Inhibition of Human Plasmacytoma Cell Growth by a Novel JAK Kinase Inhibitor
Sydney 2005: Combination of Tipifarnib & Bortezomib Results in Synergistic MM Cell death...
Sydney 2005: Cancer Vaccine Treatment and Antibody Therapy in MM
Sydney 2005: Tumour Lysate Dendritic Cell Vaccination in Multiple Myeloma
Sydney 2005: Tumor Antigen Immunization of Human Allotransplant Donors in Myeloma
Sydney 2005: DNA Vaccination Against Myeloma Post Autologous or Allogeneic Transplantation
Sydney 2005: Dendritic Cell-Based Vaccination and Beyond
Sydney 2005:
Drug Resistance in Multiple Myeloma
Sydney 2005: Anti-apoptotic Signalling in Multiple Myeloma Cells: Therapeutic Implications
Sydney 2005: Mechanisms of Drug Resistance Towards Thal and IMiDs in MM cells: role of C/EBPb
Sydney 2005: Lack of Mcl-1 Confers Resistance to Bortezomib and Melphalan but not Doxorubicin
Summary of the Xth International Myeloma Workshop
Myeloma Minute Special Edition: Updates from the International Myeloma Workshop in Sydney, Australia
IMF Presents Research Triple Play at Xth International Myeloma Workshop
Professor Jean-Luc Harousseau Receives Prestigious Waldenstrom Award
A Brief History of the International Myeloma Workshop
Update on Lenalidomide (CC-5013; Revlimid?)
Meet New Members of the IMF Scientific Advisory Board
Supportive Care: Erectile Dysfunction - Current Treatment Options
ASH 2004 - Rajkumar
ASH 2004 - Jagannath
ASH 2004 - Richardson
ASH 2004 - San Miguel
ASH 2004 - Dimopoulos
Report from the Atlanta 2005 Patient & Family Seminar
IMF Myeloma Bracelet - Imagine Moving Forward
Myeloma Minute - May 6, 2005
Bank On A Cure? Frequently Asked Medical Questions
Bank On A Cure? Scientific Advisory Board
Bank On A Cure? IMF Patient Programs and Services
Bank On A Cure? Brian Van Ness, Ph.D.
Bank On A Cure? Brian G.M. Durie, M.D.
Bank On A Cure? Susie Novis, President, International Myeloma Foundation
Bank On A Cure? Susie Novis, President, International Myeloma Foundation
IMF Hotline Coordinators Answer Your Questions
Supportive Care: Blood Tests
Dallas Patient & Family Seminar
Community Goals Lead to Results
IMF Receives Highest Four-Star Rating
Sorority Raises Funds for a Cure
Myeloma Foundation of Australia Inc.
Webcast of the Official Launch of BANK?ON?A?CURE?
So, What?s Up With Revlimid?
Myeloma Minute - May 16, 2005
2005 Brian D. Novis Research Grants
Did You Know: What Causes Hyperviscosity in Multiple Myeloma?
JC?s Support for Myeloma Patients Grows
Myeloma Minute - May 22, 2005
Myeloma Minute - July 10, 2005
I Have Myeloma....What's Next?
Team Milers Against Myeloma
San Diego Rock ?n Roll Marathon
First meeting of the Israeli Myeloma Working Group to be held on July 29, 2005
INTERNATIONAL NON-PROFIT DECORATES PACIFIC NORTHWESTERN MEDICAL COMMUNITY WITH ANNUAL RIBBON OF HOPE
Myeloma Minute - August 14, 2006
Myeloma Minute - July 3, 2005
Documentary Film Company Searching for Myeloma Patients Who Are Taking Thalidomide
Understanding Quadramet®
Myeloma Minute - July 31, 2005
Myeloma Minute - July 22, 2005
History is Made with the First Meeting of the Israeli Myeloma Study Group
Ministry Recap and Reflection - July 2005
Myeloma Minute - August 22, 2005
Multiple Colors for Multiple Myeloma
Myeloma Minute - September 2, 2005
Myeloma Minute - September 13, 2005
An old hometown needs help
ACTION ALERT! Congress Can?t Agree on Spending Bill.
International Myeloma Foundation Patient Handbook - Hebrew Edition
FDA postpones approval of Revlimid? for MDS
But Celgene says filing for myeloma remains on track
Patient Perspective: A Conversation with Tim and Donna Egan
Patient Perspective: Cancer Etiquette
Apprendimento VELCADE® (bortezomib) per iniezione
Myeloma Minute - November 21, 2005
Third Annual Myeloma Days in Istanbul Draws Over 100 Attendees
Phase II VELCADE® Clinical Trials
Myeloma Minute - January 10, 2006
Myeloma Minute - October 28, 2005
Phase IV REVLIMID? Trial (Expanded Access Protocol or EAP)
REVLIMID? EXTENDS SURVIVAL WITH POSITIVE IMPLICATIONS FOR A WIDE RANGE OF BLOOD CANCERS
IMF Says Revlimid Approval Could Benefit Patients Throughout Europe
IMF: La recomendaci?n de la aprobaci?n de REVLIMID® puede beneficiar a pacientes en toda Europa
Der Vorschlag zur Genehmigung von REVLIMID(R) k?nnte sich laut der International Myeloma Foundation zum Patientenwohl in ganz Europa auswirken
Международный фонд борьбы с миеломой заявляет о том, что рекомендация одобрить REVLIMID(R) может помочь больным во всей Европе
La International Myeloma Foundation indique que la recommandation d'autorisation de mise sur le march? du REVLIMID(R) pourrait profiter aux patients de toute l'Europe
CAUTION ABOUT USE OF ERYTHROPOIETIN PRODUCTS
Kenneth C. Anderson Honored by IMF with 2005 Robert A. Kyle Lifetime Achievement Award
Over 200 Attend 2nd Annual Patient & Family Seminar in Madrid
Millennium invites Support Group Leader to XIth Myeloma Workshop in Kos, Greece
Over 300 In Attendance at Third Italian Patient & Family Seminar
ECOG REVLIMID? TRIAL HAS RESUMED
Myeloma Minute - November 7, 2005
Heinz Ludwig ASH 2005
Webcast of Dr. Hartmut Goldschmidt at ASH 2005
Webcast of Dr. Meryl Beksac at ASH 2005
Revlimid Update: Where Do We Stand?
Total Therapy III Update
Medicare Deadline Reminder
Un informe del Segundo Congreso Europeo para Enfermedades Hematol?gicas
Report from the 2nd European Congress on Hematological Malignancies
Living Successfully with Multiple Myeloma
Czech Patient & Family Seminar - September 2-3, 2005
Music Against Myeloma
Report from Madrid
I met Dr. Brian Durie more than 30 years ago...
Myeloma Minute - Special Edition:
FDA Grants 'Priority Review' for Revlimid
Don?t be misled by news reports that say thalidomide stops working for myeloma patients.
Myeloma Minute - March 14, 2006
Myeloma Minute - March 21, 2006
Fourth Annual Robert A. Kyle Lifetime Achievement Award Tribute Journal
Fourth Annual Robert A. Kyle Lifetime Achievement Award Event Details
Fourth Annual Robert A. Kyle Lifetime Achievement Award Sponsors
Verwirrende neue Geschichten ?ber die Effektivit?t von Thalidomid; was bedeutet dies?
Study Finds Patients Agree on Ideal Physician Behaviors
Eine Studie der Mayo-Klinik findet Patienten-Zustimmungzum idealen Verhalten von ?rzten
Mozobil ? ein neues Medikament zur Sammlung von Stammzellen
Kongressbericht: Symposium ?Das Multiple Myelom 2006: auf dem Weg zur Heilung??
Revlimid? Accepted by EMEA for Evaluation as Oral Therapy for Relapsed or Refractory MM
Myeloma Minute - April 5, 2006
Marktzulassungsantrag für LENOLIDAMID von EMEA zur Überprüfung angenommen
EMEA sta valutando LENOLINOMIDE come terapia orale per la cura di pazienti con mieloma recidivo
L'EMEA accepte d'?valuer la demande d'autorisation de mise sure le march? de la LENALIDOMIDE
La EMEA analiza la solicitud de comercialización de LENALIDOMIDA
Revlimid? Accepted by EMEA for Evaluation as Oral Therapy for Relapsed or Refractory MM
Myeloma Minute - April 11, 2006
Myelom Merkur - Ausgabe, April 2006
Our Guiding Light Shines Bright
16th Anniversary Gala Sponsors
Scheduled Speakers for the Fourth Annual Robert A, Kyle Lifetime Achievement Award
The IMF Launches Website for Global Spanish-Speaking Community
La IMF lanza un sitio Web para la comunidad mundial de habla espa?ola
Myeloma Minute - April 19, 2006
συνέντευξη - Dr. Meletios-Athanassios Dimopoulos
Polskie Stowarzyszenie Pomocy Chorym na Szpiczaka
The Yin and Yang of Long-Term Survivorship
American Society of Hematology - 47th Annual Meeting
Dear Reader
The Stafford Family Funds Myeloma Research Grant
Flavia Hiatt Shares Her Story
2006 IMF Brian D. Novis Research Grant Awards
Combination Therapy with VELCADE plus Melphalan & Prednisone
Pain Management in Multiple Myeloma
Transplant Nutrition
My Life With Myeloma
Challenging Cancer with the Power of Painting
Board of Directors Profile: Matthew Robinson
IMFers MAKE A DIFFERENCE!
2005 Member Fundraisers in Review
2005 Support Group Recap
Central Nebraska Myeloma Support Group
The IMF Returns to St. Petersburg, Russia
IMF Hotline Coordinators Answer Your Questions
Dalsu Baris, MD, PhD
House Budget Inaction Stalls Senate?s Cancer Funding Momentum
Myeloma Minute - April 26, 2006
Myeloma Minute - May 2, 2006
Mensajero del Mieloma
House Leadership Presses for Budget Bill Opposed by Health Advocates
Myeloma Minute - May 10, 2006
House Leadership Uses Obscure Procedural Move to Cap Spending Levels
Myeloma Minute - May 18, 2006
Dear Reader
Patient Perspectives: NUMBERS DON'T LIE, or do they?
IMF Around the Globe: Israeli Association of Myeloma Patients
Sixth Annual Support Group Leader Retreat
Making Clinical Trials More Patient-Friendly
Pathogenesis and Maintenance of Multiple Myeloma
MOZOBIL?, a potential new agent for Stem Cell Harvesting
Patient Experience: One Day at a Time...for 18 Years
Education, Advocacy, and Awareness: Profile of Robin Tuohy
IMF Hotline Coordinators Answer Your Questions
The Multiple Myeloma ListServe
IMF Around the Globe: ?The Greater Montreal Multiple Myeloma Support Group
Member Events: Gary C. Heuer, Jr. Memorial Golf Tournament
Fundraising: Rocking in Rhode Island
Fundraising: Katie's Birthday Charity Bash
South Florida's Dynamic Duo: Cindy Feltzin and Vicki Anderson Ferraro
Scientific & Clinical: VELCADE® phase III trials
IMF Board Member Interview with Benson and Carol Klein
Insights into New Myeloma Tx: Revlimid Study Tops List of Investigations that may Benefit Patients
Member Events: 4th Annual MMAMM Benefit Keeps Lee Grayson's Memory Alive
On the Road with the IMF Support Team
Advocacy Update: Senators Outraged by Decreased Research Funding
THE INTERNATIONAL MYELOMA FOUNDATION APPLAUDS FDA APPROVAL OF THALOMID? FOR MYELOMA PATIENTS
Myeloma Minute - May 24, 2006
Ralph Ferrizzi Memorial Golf Tournament
My Journey Through Myeloma
Myeloma Minute - May 31, 2006
ASCO 2006 Overview with Dr. Durie
Myeloma Minute - June 7, 2006
2006 IMF Support Group Leaders? Retreat
Report from ASCO 2006
ASCO 2006 INDUSTRY NEWS
Myeloma Minute - June 14, 2006
7th Annual JC Golf Tournament a Stellar Success!
IMF Receives Grant from Goldman Philanthropic Foundation for Bank On A Cure®
16th Anniversary Gala Sponsor Opportunities
2006 Robert A. Kyle Lifetime Achievement Award; Report from the Dinner Chairs
The International Myeloma Foundation Unveils Plans for MYELOMA MOBILE to Travel Across the U.S. this Summer
1845
AMEN's First Anniversary
AMEN's First Anniversary
Myeloma Minute - June 21, 2006
REVLIMID? APPROVAL FOR MYELOMA CAN BE LIFE-CHANGING FOR CANCER PATIENTS
Myeloma Minute Special Edition: Revlimid® Approved for Myeloma!
Prediction of response to therapy with clarithromycin/lenalidomide/dexamethasone (BIRD) in MM
Lenalidomide plus high-dose dex provides improved overall survival compared to high-dose dex alone
Oral lenalidomide plus melphalan and prednisone (R-MP) for newly diagnosed multiple myeloma.
Myeloma Minute - June 30, 2006
Correlation of bone marrow angiogenesis & response to thalidomide Dexamethasone in multiple myeloma
An Overview of Key Presentations at ASCO 2006
Un resumen de las presentaciones claves de ASCO 2006
Myeloma Minute - July 7, 2006
ASCO 2006
Partnership for Cure's Concert for Cures Nets $25,000 for Bank? On A Cure
An Overview of the Role of Novel Therapies in Previously Untreated Myeloma
Comparison of lenalidomide with dexamethasone to dex alone in patients who've received prior thalid
Multicenter, randomized, double-blind, placebo-controlled trial of thalidomide plus dex vs dex
Dose-escalating & pharmacologic study of bortezomib in adult cancer pts with impaired renal function
Single-agent bortezomib in previously untreated MM:
Results of a phase II multicenter study.
Randomized, Active-controlled Study of Denosumab (AMG 162) in Breast Cancer Patients with
Rock On!
ASCO 2006: A Commentary
?Qu? es el Mieloma?
Update on Multicenter Atiprimod Trial
Myeloma Minute - July 26, 2006
Part I
AMEN Hosts Myeloma Seminar for Hematology Residents
Myeloma Minute - July 26, 2006
Part II
RUN THE NYC MARATHON AND FIGHT MYELOMA
ASCO 2006
ASCO 2006
ASCO 2006
Summer 2006 Myeloma Today in PDF
Spring 2006 Myeloma Today in PDF
Myeloma Minute - August 6, 2006
Leading Cancer Experts Conduct Philadelphia Seminar on MM Treatment as New 'Model' for Cancer Care
Comprendre Revlimid®
Comprendre La Dexaméthasone et Autres Stéroïdes
Out and About in Beverly Hills
Myelom Merkur - Ausgabe, August 2006
Myelom Merkur - Ausgabe, Mai 2006
An IMF tip-sheet: How to Round Out Your Trip to the IMF's 16th Anniversary Gala
Myeloma Minute - August 30, 2006
Myeloma Minute - May 1, 2007
Report from the 2nd Annual Czech Myeloma Group Patient Seminar
INTERIM FINDINGS FROM GLOBAL TRIAL EXTEND POSITIVE BENEFITS OF VELCADE TO NEWLY DIAGNOSED PATIENTS
Live Auction Items for the IMF's 16th Anniversary Gala on October 21
Igor Sill
E. Michael D. Scott
An American in Paris?
Myeloma Minute _ September 22, 2006
Have You Made Your New Year's Resolutions Yet!
ASH 2006 Highlights for Patients with Myeloma
Report from the 4th Annual Paris Patient & Family Seminar
Myeloma Minute - October 5, 2006
Report from the Fourth Annual Italian Patient & Family Seminar
Myeloma Minute - October 17, 2006
Understanding VELCADE® (bortezomib) for Injection Therapy
Understanding Thalidomide Therapy
Fall 2006 Myeloma Today in PDF
Conociendo Revlimid
What a Night! Report from the IMF's 16th Anniversary Gala
Myeloma Minute - November 3, 2006
New IMF Nurse Leadership Board Meets to Develop Recommendations for Care
The IMF in Atlanta
Myeloma Minute - November 11, 2006
Conociendo Dexametasona y Otros Esteroides
Das Handbuch zur Ballon Kyphoplastik „Ballon Kyphoplastik und Myelom-induzierte Wirbelfrakturen verstehen"
国際骨髄腫財団：国際癌会議における数々の研究報告。新治療方法に関して血液癌患者に明るい展望
The Use of Velcade as First-Line Therapy in High-Risk Myeloma
The Use of Lenalidomide +/- Dexamethasone in Patients with AL Amyloidosis
Long-Term Follow-Up of a Phase II Trial of Vel/Dex in Frontline Therapy for Myeloma
The Genetic Contribution to the Etiology of Thalidomide-Associated VTE
Long Term Results of a Study of Rev/Dex in Newly Diagnosed Patients
A Phase I Study of Novel Proteasome Inhibitor PR-171 (carfilzomib)
Identification of Mutations in the NFkB Pathway That Predict Velcade Response
Breaking the Plateau Response in MM: Results of a Pilot Study of Vel/Dex/Doxil (DoVeD)
Velcade Added to High-Dose Cytoxan and GCSF as a Mobilization Regimen for Stem Cell Collection Prior to HDT

Revlimid-Induced Myelosuppression is Potentially Associated with Renal Dysfunction in Treatment-Naïve MM Patients Receiving BiRD
A Randomized Study of Lenalidomide with High- or Low-Dose Dexamethasone in the Treatment of Newly Diagnosed Myeloma
Revlimid in Combination with Dex is More Effective than Dexamethasone Alone at First Relapse
SNP Association with Event-Free Survival (EFS) in Myeloma from Two Phase III Trials Using the Bank On A Cure SNP Chip

Relationship Between Quality of Response to Velcade and Clinical Benefit

A Phase I Study of HCD122 (formerly CHIR-12.12), a Monoclonal Antibody to CD40, in Relapsed/Refractory Myeloma

A Phase II Study of Velcade, Doxil, and Thalidomide (VDT) in Relapsed/Refractory Myeloma

Analysis of Phase III Study of Revlimid/Dexamethasone vs. Dexamethasone Alone in Patients >65 Years

Phase I Study of BB-10901 (huN901-DM1) in Patients with Relapsed/Refractory CD56-Positive Myeloma

An Analysis of Response Criteria Post-Stem Cell Transplant in AL Amyloidosis

An Overview of ASH 2006
Phase III International Randomized Study of Velcade vs Velcade/Doxil in Relapsed/Refractory Myeloma

Velcade and Doxil as Induction Therapy for Newly Diagnosed Myeloma

New Proteasome Inhibitor NPI-0052

A Retrospective Analysis of Three Induction Regimens for Newly Diagnosed Myeloma Prior to Transplant

A Retrospective Analysis of the Significance of Measurable Disease at Time of Transplant

A Retrospective Analysis of High-Dose Therapy in Patients with Renal Insufficiency

Mi-63, a Small Molecule Inhibitor of MDM2-p53 Interaction, Has Significant In Vitro Activity in Multiple Myeloma

An Overview of ASH 2006
Use of Revlimid With or Without Steroids in Relapsed/Refractory Myeloma in Patients with Elevated Baseline Serum Creatinine

Phase I/II Study of Oral Cyclophosphamide, Prednisone, and Velcade in Patients with Relapsed/Refractory Myeloma

An International Randomized Trial of Thalidomide/Dexamethsone vs Dexamethasone Alone

A Retrospective Study of the Significance of VGPR/CR in the IFM 99 Trials

An Interim Analysis of Velcade/Dexamethasone vs VAD as Induction Therapy Prior to Transplant in Newly Diagnosed Myeloma

Prospective Randomized Comparison of Double Transplant with Melphalan 200 vs Triple Transplant with Melphalan 100

Amplification of 1q21 Is Associated with Poor Outcome after Treatment with Bortezomib in Relapsed/Refractory Multiple Myeloma

IMF Promotes David Smith to Executive Director
2007 Brian D. Novis Grant Winners Announced at ASH
Combination of Revlimid and Velcade in the Treatment of Relapsed/Refractory Myeloma

Phase I Study of KOS-953 + Velcade in Patients with Relapsed/Refractory MM
A Retrospective Study of the Significance of Complete Response (CR) on Outcomes in Myeloma Treatment

A Subset of Revlimid/Dexamethasone vs Dexamethasone Alone After Thalidomide Therapy in Relapsed/Refractory Myeloma
The Use of Velcade + Melphalan and Prednisone in Elderly Non-Transplant Patients

A Phase II Study of Alternating Velcade and Dexamethasone as Induction Therapy Prior to Transplant in Newly Diagnosed Patients

An Overview of Planned Randomized Clinical Trials for Newly Diagnosed Younger and Older Patients in Spain

Phase I/II Study of Revlimid + Melphalan/Prednisone (R-MP) for Newly Diagnosed Myeloma

Phase I/II Study of a Combination of Velcade, Melphalan, Prednisone, and Thalidomide (VMPT) for Relapsed Myeloma

Sue Sumpter's Blog from ASH 2006
Paula Van Riper's Blog from ASH 2006
Jack Aiello's Blog from ASH 2006
An Overview of ASH 2006
The IMF Mourns the Passing of Cathy Lebkuecher, winner of the Francesca Thompson Outstanding Service Award for her work with myeloma patients.
A Phase I/II Study of Revlimid, Adriamycin, and Dexamethasone (RAD) in Patients with Relapsed/Refractory Myeloma
ASH 2006 Güncel özet
The Effect of Genetically Modified Measles Virus on Myeloma Cells in Vitro

A Phase I/II Study of Consolidation Therapy with Velcade after Tandem Transplant

Winter 2006 Myeloma Today in PDF
German Translation of The Effect of Genetically Modified Measles....
German Translation for Consolidation Therapy video
STUDY SHOWS VELCADE® PLUS DOXIL® IMPROVES SURVIVAL IN PREVIOUSLY TREATED PATIENTS WITH MYELOMA
Un R?sum? du Congr?s de la Societ? Am?ricaine d?Hematologie (ASH) 2006
The F.O.R. (Friends of Richie) Benefit Story
IMF's Multiple Myeloma Quilt of Courage 5
Overview of ASH 2006 in Hebrew

Multiple Myeloma Quilt of Courage #5 - To Honor Tom Finnerty
Myeloma Quilt of Courage #5 - In Memory of Rich Ramsaier
Multiple Myeloma Quilt of Courage #5 - To Military and Ex-Military
Multiple Myeloma Quilt of Courage #5 - To Honor Jerry Simpson
Multiple Myeloma Quilt of Courage #5 - By Reino Melse Meenks
Multiple Myeloma Quilt of Courage #5 - In Memory of Fritz Steppat
Multiple Myeloma Quilt of Courage #5 - In Memory of Jim Potter
Myeloma Quilt of Courage # 5 - By Karen Maru
Myeloma Quilt of Courage #5 - In Memory of Christal Mann Albert
Myeloma Quilt of Courage #5 - In Memory of Dick T. Jordan, Jr.
Myeloma Quilt of Courage #5 - In Memory of Tim Woomer
Myeloma Quilt of Courage #5 - In Memory of Nancy Ann Phillips
Myeloma Quilt of Courage #5 - For Walter (Peter) Carr
Myeloma Quilt of Courage #5 - For Stanley Sablock
Myeloma Quilt of Courage #5 - By Debbie Tidwell
Myeloma Quilt of Courage #5 - To Honor All Those on the ACOR Myeloma Listserv
Myeloma Quilt of Courage #5 - By Myde Stocker
Myeloma Quilt of Courage #5 - In Memory of Bill Bertsche
Myeloma Quilt of Courage #5 - In Memory of Claire E. Wehrlen
Turn Your Vacations Into Donations!
Support Group Leader Blogs from ASH 2006
Myeloma Minute - January 23, 2007
LEADING CANCER EXPERTS TO CONDUCT LOS ANGELES SEMINAR ON MYELOMA TREATMENT AS THE "NEW MODEL" FOR CANCER CARE
Myeloma Minute - February 3, 2007
INDEPENDENT SURVEY RATES THE INTERNATIONAL MYELOMA FOUNDATION THE #1 RESOURCE FOR PATIENTS
Myeloma Minute - February 13, 2007
2005 Brian D. Novis Grant Winners
ASH 2006 Multiple Myeloma Highlights for Physicians
IMF Travel Advantage Newsletter
Your Travel Helps Fund the IMF
David H. Vesole, MD, PhD, FACP
Treatment of Newly Diagnosed Myeloma Based on Mayo Clinic's mSMART
Heather Cooper Ortner Named IMF Vice President of Development
ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports LENALIDOMIDE Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
Myeloma Minute - April 5, 2007
THE INTERNATIONAL MYELOMA FOUNDATION SAYS ECOG RESULTS COULD IMPROVE SURVIVAL WHILE REDUCING SIDE EFFECTS FOR MANY PATIENTS
Scientific Advisory Board
CELGENE LAUNCHES NEW ?PATIENT SUPPORT COORDINATOR? PROGRAM AT IMF MEETING OF SUPPORT GROUP LEADERS IN PHOENIX
Route for Myeloma Mobile Finalized
New England Journal of Medicine Sites Myeloma as Concern for Firefighters at 9-11 Scene
IMF Satellite Symposium at ONS - a huge success!
Myelom Merkur - 3. Ausgabe, April 2007
Myelom Merkur - 5. Ausgabe, January 2007
Myelom Merkur - Januar 2007
2. Jahrgang, 1. Ausgabe
Myeloma Today Spring 2007 in PDF format
2nd Annual Music Against Myeloma Raises 10K for IMF
IMF REPORTS POSITIVE SHIFT IN TREATMENT PARADIGM FOR PATIENTS
NEW DRUG COMBINATION - VELCADE® PLUS DOXIL® - APPROVED FOR MYELOMA
Myeloma Minute Special Edition: NEW DRUG COMBINATION - VELCADE® PLUS DOXIL® - APPROVED FOR MYELOMA
Myeloma Minute - May 22, 2007
URGENT Advocacy Alert for Myeloma Patients:Reimbursement at Risk for ESAs for Management of Anemia
Phase II study of total therapy 3 (TT3) with added bortezomib (V) for multiple myeloma.

Prediction of response and progression in multiple myeloma (MM) with serum-free light chains (sFLC): Corroboration of the International Myeloma Working Group (IMWG) criteria.

Current status of stem cell transplantation: When? How Many? Allogeneic v Autologous or Both?

A PETHEMA study of high-dose therapy/stem cell support (HDT), including tandem transplant, in primary refractory multiple myeloma

Effect of the combination of pegylated liposomal doxorubicin and bortezomib on time to progression (TTP) and overall survival of patients with relapsed/refractory multiple myeloma compared with bortezomib alone.

Outcome of patients relapsing early after autologous stem cell transplantation for multiple myeloma

Phase III trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma (E4